4.17
price up icon0.72%   0.03
after-market Handel nachbörslich: 4.18 0.010 +0.24%
loading

Finanzdaten der Achieve Life Sciences Inc-Aktie (ACHV)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
20.68%
5.32
6.707 7.097 7.296 7.609
Costs And Expenses
16.95%
14.69
12.56 12.89 12.19 12.47
Depreciation and Amortization
1.82%
0.054
0.055 0.062 0.058 0.057
Nonoperating Income/Loss
261.94%
0.251
-0.155 0.067 -0.17 -0.046
Income/Loss From Continuing Operations Before Tax
15.52%
-14.69
-12.72 -12.83 -12.36 -12.47
Income/Loss From Continuing Operations After Tax
13.55%
-14.44
-12.72 -12.83 -12.36 -12.51
Net Income/Loss
13.55%
-14.44
-12.72 -12.83 -12.36 -12.51
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
47.09%
51.02
34.69 34.69 0.8191 34.36
Diluted Average Shares
47.09%
51.02
34.69 34.69 0.8191 34.36
Basic Earnings Per Share
24.32%
-0.28
-0.37 -0.37 -0.36 -0.36
Diluted Earnings Per Share
24.32%
-0.28
-0.37 -0.37 -0.36 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):